Results 151 to 160 of about 5,342 (246)

Evaluation of the long-term efficacy and safety of dydrogesterone in the treatment of endometriosis/dysmenorrhea. [PDF]

BMC Womens Health
Zhang J, Wang A, Xue L, Wu Y, Zhang Y, Li B.   +5 more
europepmc   +1 more source

Congenital anomalies after first-trimester dydrogesterone therapy during in vitro fertilization. [PDF]

Reprod Biol Endocrinol
Yang W, Zeng L, Chen L, Yang R, Wang H, Liu P, Lian Y, Li R, Chi H, Qiao J.   +9 more
europepmc   +1 more source

Association between serum progesterone concentration on the day before frozen embryo transfer and pregnancy outcomes

Revista Cubana de Medicina Militar
Introduction: Progesterone is a key hormone linked to in vitro fertilisation outcomes, and serum progesterone is a significant marker before embryo transfer.
Hang Doan Thi, Thanh Trinh Quoc, Phuong Nguyen Minh, Thien Trinh An, Hanh Pham M., Son Trinh The, Tuan Tran Van , Nhat Nguyen Ngoc   +7 more
doaj  

Efficacy of Oral Dydrogesterone in Improving Neonatal Birth Weight Outcomes in Idiopathic Intrauterine Growth Restriction: A Prospective Observational Study. [PDF]

Cureus
Kasi N, Nama N.
europepmc   +1 more source

Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations. Climacteric. 2009 Sep 1:1-11.

, 2010
C. M. Schneider, Jick SS, CR Meier
openalex   +2 more sources

Dydrogesteronevsprogesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials [PDF]

, 2015
M. W. P. Barbosa, Luís R. Silva, Paula Andrea Navarro, Rui Alberto Ferriani, C.O. Nastri, Wellington P. Martins   +5 more
openalex   +1 more source

First-Trimester Uterine Artery Doppler Indices and Pregnancy Outcomes in Naturally Conceived and Frozen-Thawed Embryo Transfer Cycles. [PDF]

Diagnostics (Basel)
Aygün EG, Kahraman E.
europepmc   +1 more source

Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technologies (ART) cycles. [PDF]

JBRA Assist Reprod
Souza MM, Souza MDCB, Antunes RA, Barbeitas AL, Raupp VA, Souza ALBM, Silva LABD, Mancebo ACA, Sequeira FF.   +8 more
europepmc   +1 more source

Why does the latest pharmacovigilance data not reflect clinical experience with dydrogesterone? [PDF]

Hum Reprod Open
Pabuccu E, Aguilar A, de Azevedo Antunes R, Gefen E, Shulman LP.   +4 more
europepmc   +1 more source

A systematic review of dydrogesterone for the treatment of threatened miscarriage

, 2012
Howard Carp
openalex   +2 more sources